RaghaVSureshMD

PubMed

• Bruton's tyrosine kinase inhibition for the treatment of allergic disorders.
  Erica V Lin, Ragha V Suresh, Melanie C Dispenza> ;Annals of Allergy, Asthma & Immunology. 2024 Mar 14
• 2 citations
  A phase II study of Bruton's tyrosine kinase inhibition for the prevention of anaphylaxis.
  Ragha V Suresh, Collin Dunnam, Dhananjay Vaidya, Robert A Wood, Bruce S Bochner, Donald W MacGlashan Jr, Melanie C Dispenza> ;The Journal of Clinical Investigation. 2023 Aug 15
• Bruton's tyrosine kinase inhibition for the prevention of anaphylaxis: an open-label, phase 2 trial.
  Ragha V Suresh, Collin Dunnam, Dhananjay Vaidya, Robert A Wood, Bruce S Bochner, Donald W MacGlashan Jr, Melanie C Dispenza> ;Research Square. 2023 Apr 5
• 3 citations
  Increase in Epinephrine Administration for Food-Induced Anaphylaxis in Pediatric Emergency Departments from 2007 to 2015
  So Lim Kim, Ragha Vasantha Suresh, Anoop Mayampurath, Christina E. Ciaccio> ;The Journal of Allergy and Clinical Immunology. in Practice. 2021 Sep 23
• 3 citations
  Reticular erythematous mucinosis: A rare cutaneous mucinosis
  Amer Ali Almohssen, Ragha Vasantha Suresh, Robert A. Schwartz> ;Acta Dermatovenerologica Croatica. 2019 Apr 25
• 15 citations
  Quality assessment of online patient education resources for peripheral neuropathy.
  David R. Hansberry, Ragha Suresh, Nitin Agarwal, Robert F. Heary, Ira M. Goldstein> ;Journal of the Peripheral Nervous System. 2013 Mar 1
• Join now to see all